Timothy McGarity, MD
Ophthalmology · Columbia, MONPI 1780614560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 27.1% of the total.
Across 124 payments — averaging $31.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$1K
- Ivantis, Inc$593
- Alcon$591
- Rxsight Inc$584
- AbbVie$344
- Glaukos Corporation$182
- plus $589 from 10 others
Across 1 payment — averaging $2800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ivantis, Inc$3K
What the payments were for
- Speaking & faculty fees$321%
- Food & beverage$3,92199%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 32 | $1,071 |
| Ivantis, Inc | 19 | $593 |
| Alcon | 27 | $591 |
| Rxsight Inc | 8 | $584 |
| AbbVie(2 entities) | 12 | $344 |
| Glaukos Corporation | 8 | $182 |
| NEW World Medical,inc. | 3 | $142 |
| Bausch & Lomb Americas Inc. | 2 | $116 |
| Kala Pharmaceuticals, Inc. | 5 | $104 |
| Oyster Point Pharma, Inc. | 1 | $83 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Tarsus Pharmaceuticals, Inc. | 1 | $28 |
| Omeros Corporation | 1 | $19 |
| Harrow Eye, LLC | 1 | $19 |
| Rayner Intraocular Lenses Limited | 1 | $17 |
| Alcon Research LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,953 in reported general payments places this provider in the 70th percentile of 286 ophthalmology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $3,378 |
| Latanoprost | 195 | $2,880 |
| Prednisolone Acetate | 31 | $962 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 47 | $698 |
| Timolol Maleate | 27 | $525 |
| Dorzolamide Hcl | 23 | $503 |
| ValacyclovirValacyclovir Hcl | 11 | $357 |
| Brimonidine Tartrate | 23 | $140 |
| Acyclovir | 13 | $113 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Columbia
- Jella AnColumbia$166K
- Mai PhamColumbia$17K
- John McCannColumbia$8K
- Steven SilversteinKansas City$872K
- Ranjan MalhotraSaint Louis$809K
- Nancy HolekampChesterfield$768K
- Jay PeposeChesterfield$516K
- Gregg BerdySaint Louis$360K
- Joseph GiraDes Peres$174K
- Joseph TauberKansas City$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.